Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH + Semaglutide in Non-Diabetic Obesity
NCT06863363Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of peg-somatropin in obesity, sponsored by Zhongshan Hospital, Fudan University. Status: not yet recruiting.
02
Drugs
peg-somatropin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06863363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06863363.